PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Mini-Reviews in Medicinal Chemistry0 citations

Research Progress on Targeted Inhibition of Ferroptosis and Alzheimer'sDisease Treatment

View Full Paper
ALAnnan LiuJLJianhui LiWGWei Gao

Key Points

  • Alzheimer's disease treatment shows promise in targeting ferroptosis as a significant pathway.
  • Studies indicate increased iron loading and oxidative stress lead to cell death in Alzheimer's disease.
  • Analysis of recent advances in the role of ferroptosis suggests new therapeutic options for Alzheimer’s disease.
  • Targeting ferroptosis may reveal new strategies for prevention and treatment of Alzheimer's disease.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the formation of senile plaques and neurofibrillary fiber tangles. Studies have shown that increased regional iron loading in the brain, dysregulation of iron homeostasis in the body, oxidative stress, and protein and lipid oxidation are all involved in the pathogenesis of AD. Ferroptosis, an irondependent, lipid peroxidation-driven form of regulated cell death, is increasingly implicated in the pathological process of AD, and some new compounds targeting ferroptosis demonstrate therapeutic efficacy in both cellular and animal models of AD. Therefore, this article systematically summarizes recent advances in the role of ferroptosis in AD pathogenesis and highlights progress in targeting ferroptosis for AD treatment, providing insights for future therapeutic and preventive strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2026) studied this question.

synapsesocial.com/papers/69a75ae3c6e9836116a2152chttps://doi.org/10.2174/0113895575411431251125115235
Ask AI
Helpful
Bookmark
Share
View Full Paper